Activin Receptor Type IIB/ACVR2B Antibody [A7P16]

製品コード:F2986

印刷

生物学的記述

Specificity Activin Receptor Type IIB/ACVR2B Antibody [A7P16] detects endogenous levels of total Activin Receptor Type IIB/ACVR2B protein.
Background Activin Receptor Type IIB/ACVR2B (ActRIIB) is a transmembrane serine/threonine kinase receptor belonging to the type II receptor family of the transforming growth factor-β (TGF-β) superfamily, essential for activin and myostatin signaling. It is widely expressed in various tissues, including skeletal muscle, reproductive organs, and the nervous system, where it regulates diverse biological processes such as cell growth, apoptosis, fibrosis, inflammation, neurogenesis, and muscle homeostasis. Structurally, ACVR2B is composed of an extracellular ligand-binding domain, a single-pass transmembrane helix, and a cytoplasmic serine/threonine kinase domain. The extracellular domain binds activins with high affinity and interacts preferentially with myostatin (GDF-8), while the intracellular kinase domain phosphorylates downstream type I receptors (such as ALK4/ActRIB for activin and ALK5/TβRI for myostatin) to initiate SMAD-dependent transcriptional responses. ACVR2B kinase domain displays a conserved bilobal fold, with a small N-terminal lobe containing β-sheets and an αC helix, a larger C-terminal lobe with the activation loop, and a hinge region forming the ATP-binding pocket. Unique structural features, including Thr265 as a gatekeeper residue and a back pocket stabilized by Phe247, distinguish ActRIIB within the type II receptor subfamily and make it a promising drug target. Functionally, ACVR2B mediates activin-induced follicle-stimulating hormone (FSH) regulation and myostatin-mediated inhibition of skeletal muscle growth, making it highly relevant in conditions such as muscular dystrophy, sarcopenia, cachexia, diabetes, and fibrosis, and its structure provides a framework for the design of selective inhibitors for therapeutic intervention.

使用情報

Application WB, FCM, ELISA Dilution
WB FCM
1:500 1:800
Reactivity Human
Source Mouse Monoclonal Antibody MW 58 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

References

  • https://pubmed.ncbi.nlm.nih.gov/21353874/

Application Data

WB

Validated by Selleck

  • F2986-wb.gif
    Lane 1: 293T (transfected with IIB/ACVR2B), Lane 2: 293T